Sharekhan

Fischer Medical Ventures Ltd

Fri 29/08/2025,15:57:40 | NSE : FISCHER

₹ 1056.759.65 (0.92%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1050.00

Previous Close

₹ 1047.10

Volume

38533

Mkt Cap ( Rs. Cr)

₹6742.23

High

₹ 1076.00

Low

₹ 1015.00

52 Week High

₹ 1085.00

52 Week Low

₹ 770.10

Book Value Per Share

₹ 14.19

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Fischer Medical Ventures Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1056.75

300

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

300

Option Chain

Analyzes market sentiment, predicts Fischer Medical Ventures Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fischer Medical Vent has declared 0.50% Final dividend for the financial year March 2025

    22 Aug 2025, 11:47AM Fischer Medical Ventures Ltd. on Wednesday, 28 May 2025, has announced Final dividend of 0.50 percent on Equity Share, to its shareholders holding sha
  • Fischer Medical Vent - General Updates

    18 Aug 2025, 11:34AM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - General Update

    18 Aug 2025, 11:32AM General Update
  • Fischer Medical Vent - Outcome Of Board Meeting Held On 14.08.2025

    15 Aug 2025, 10:17AM Outcome of Board Meeting held on 14.08.2025 relating quarter results for the quarter ended 30.06.2025
  • Fischer Medical Vent - General Updates

    15 Aug 2025, 10:14AM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - Resignation of Independent director

    14 Aug 2025, 5:30PM FISCHER MEDICAL VENTURES LIMITED has informed the Exchange about Resignation of Independent director.
  • Fischer Medical Vent - Record Date

    14 Aug 2025, 5:25PM Fischer Medical Ventures Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Sep-2025.
  • Fischer Medical Vent - Disclosure of material issue

    14 Aug 2025, 2:15PM Fischer Medical Ventures Limited has informed regarding Disclosure of material issue
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Resignation of Director

    14 Aug 2025, 2:15PM Intimation of Resignation of Independent Director
  • Fischer Medical Vent - Outcome of Board Meeting

    14 Aug 2025, 2:10PM Fischer Medical Ventures Limited has informed the Exchange regarding Board meeting held on August 14, 2025.
  • Fischer Medical Vent - Outcome of Board Meeting

    14 Aug 2025, 2:08PM Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
  • Fischer Medical Vent - Outcome of Board Meeting

    14 Aug 2025, 1:38PM Fischer Medical Ventures Limited has informed the Exchange regarding Board meeting held on August 14, 2025.
  • Fischer Medical Vent - Corporate Action For Dividend & E- Voting - 22/09/2025

    14 Aug 2025, 5:21PM Fischer Medical Ventures Limited has informed the exchange on the Book closure date and record date relating to 32nd Annual general meeting of the Com
  • Fischer Medical Vent - Results - June 2025

    14 Aug 2025, 2:25PM Intimation of Outcome of Board Meeting dated 14.08.2025
  • Fischer Medical Vent - Results-30.06.2025

    14 Aug 2025, 2:05PM Outcome of Board meeting
  • Fischer Medical Vent - Results -30.06.2025

    14 Aug 2025, 1:51PM Intimation of Board Meeting outcome
  • Fischer Medical Vent - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2025

    14 Aug 2025, 1:36PM Outcome of Board Meeting held on 14.08.2025
  • Fischer Medical Vent - Monitoring Agency Report

    11 Aug 2025, 3:14PM Fischer Medical Ventures Ltd has informed the exchange on the receipt of Monitoring Agency Report for the quarter ended 30.06.2025
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    11 Aug 2025, 3:18PM The Company has intimated the Monitoring Agency report for the quarter ended 30th June 2025
  • Fischer Medical Vent - Board Meeting Intimation for Financial Results For The Quarter Ended 30Th June 2025 And Other Matters

    5 Aug 2025, 3:49PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to cons
  • Fischer Medical Vent - Copy of Newspaper Publication

    31 Jul 2025, 2:01PM Fischer Medical Ventures Limited has informed the Exchange about Copy of Newspaper Publication
  • Fischer Medical Vent - Shareholders meeting

    30 Jul 2025, 10:40AM Fischer Medical Ventures Limited has informed the Exchange regarding Notice of Postal Ballot
  • Fischer Medical Vent - Postal Ballot Notice Relating To Split Of Equity Shares Of The Company

    30 Jul 2025, 10:39AM Fischer Medical Ventures Ltd has informed the exchange on Notice of Postal Ballot relating to split of Equity Shares of the Company
  • Fischer Medical Vent - General Updates

    28 Jul 2025, 2:58PM Fischer Medical Ventures Limited has informed the Exchange about General Updates
  • Fischer Medical Vent - Disclosure of material issue

    28 Jul 2025, 2:36PM Fischer Medical Ventures Limited has informed regarding Disclosure of material issue
  • Fischer Medical Vent - Stock split

    28 Jul 2025, 2:30PM Fischer Medical Ventures Limited has informed the Exchange that the Board of Directors at its meeting held on July 28, 2025, has considered and approv
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    28 Jul 2025, 2:48PM Intimation of Postal Ballot for Split of Equity shares of the Company
  • Fischer Medical Vent - Disclosure under Regulation 30A of LODR

    28 Jul 2025, 2:39PM Fischer Medical Ventures has informed the exchange on the Board approval for the Split of Equity Shares of the Company and other related business item
  • Fischer Medical Vent - Board Meeting Outcome for Fischer Medical Ventures Limited Has Informed The Exchange On The Outcome Of

    28 Jul 2025, 2:27PM Fischer Medical Ventures Limited has informed the exchange on the Outcome of the Board Meeting held on 28/07/2025 relating to Split of Equity shares o
  • Fischer Medical Vent - Press Release

    24 Jul 2025, 5:32PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 24, 2025, titled ""Inauguration of Sikkim s First MRI
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 Jul 2025, 5:37PM Fischer Medical Ventures Ltd informed the exchange on the press release relating to Inauguration of Sikkim' s First MRI Facility at CGHS Rates at STNM
  • Fischer Medical Vent - Board Meeting Intimation for Consideration And Approval Of Split/ Sub Division Of Equity Shares Of The

    23 Jul 2025, 3:21PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to cons
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    21 Jul 2025, 6:40PM Fischer Medical Ventures Ltd has informed the exchange on the press release relating to Chennai's First High Resolution Open MRI inaugurated at Sunray
  • Fischer Medical Vent - Press Release

    21 Jul 2025, 6:34PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 21, 2025, titled ""Transforming Diagnostic Imaging: Ch
  • Fischer Medical Vent - Press Release (Revised)

    11 Jul 2025, 3:44PM Fischer Medical Ventures Limited has informed the Exchange regarding a revised press release dated July 10, 2025, titled ""Fischer Medical Ventures Lt
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

    11 Jul 2025, 3:44PM Fischer Medical Ventures Ltd has informed the exchange on its partnership with City of Jembur to Power Indonesia's fight against Tuberculosis
  • Fischer Medical Vent - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    11 Jul 2025, 12:55PM Fischer Medical Ventures Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Fischer Medical Vent - Press Release

    11 Jul 2025, 12:35PM Fischer Medical Ventures' JV Partner NYB.AI Clinches Top Global AI Innovation Award
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    11 Jul 2025, 12:27PM Fischer Medical Ventures JV partner Nanyang Biologics clinches top global AI Innovation award
  • Fischer Medical Vent - Press Release

    10 Jul 2025, 10:33PM Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 10, 2025, titled ""Fischer Medical Ventures Ltd partne
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    9 Jul 2025, 3:54PM Fischer Medical Ventures Ltd has informed the exchange on the acquisition of a Landmark mixed use property in Malacca
  • Fischer Medical Vent - Announcement Under Regulation 30- Listing In NSE

    9 Jul 2025, 11:58AM Fischer Medical Ventures Limited has informed the exchange on the receipt of Circular from National Stock Exchange of India (NSE) relating to Listing
  • Fischer Medical Vent - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Jul 2025, 9:54PM Fischer Medical Ventures has submitted the certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    7 Jul 2025, 5:40PM As of June 2025, 61.80% is owned by Promoters and 38.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.64% and Forei

Key fundamentals

Evaluate the intrinsic value of Fischer Medical Ventures Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 335.6851 79.6794 0.3057 0.1597 0.2359
Liabilities 335.6851 79.6794 0.3057 0.1597 0.2359
Equity 63.8015 53.5 0.172 0.172 0.172
Gross Profit -2.2373 -0.1952 0.0152 -0.1887 -0.1825
Net Profit 0.6632 0.4028 -0.0365 -0.2326 0.1406
Cash From Operating Activities -22.8064 0.0796 -0.1459 -0.1769 -0.0573
NPM(%) 12.7 3.49 -20.33 0 0
Revenue 5.2197 11.5283 0.1795 0 0
Expenses 7.457 11.7235 0.1643 0.1887 0.1825
ROE(%) 0.73 0.44 -0.04 -0.25 0.15

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fischer Medical Ventures Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 949.10 1.51 20.39 9440.22 337.37 0.95
Amines and Plasticizers Ltd 220.92 0.89 30.56 5757.02 372.61 0.23
Indogulf Cropsciences Ltd 105.57 -1.13 0.00 2460.88 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.92 47442.76 346.70 0.43

Company Info

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

Read More

Parent Organisation

Fischer Medical Ventures Ltd.

Founded

22/03/1993

Managing Director

Mr.Ravindran Govindan

NSE Symbol

FISCHEREQ

FAQ

The current price of Fischer Medical Ventures Ltd is ₹ 1056.75.

The 52-week high for Fischer Medical Ventures Ltd is ₹ 1076.00 and the 52-week low is ₹ 1015.00.

The market capitalization of Fischer Medical Ventures Ltd is currently ₹ 6742.23. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fischer Medical Ventures Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fischer Medical Ventures Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fischer Medical Ventures Ltd shares.

The CEO of Fischer Medical Ventures Ltd is Mr.Ravindran Govindan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT